Compounds > n(1),n(11)-diethylnorspermine
Page last updated: 2024-10-31

n(1),n(11)-diethylnorspermine and Central Nervous System Disease

n(1),n(11)-diethylnorspermine has been researched along with Central Nervous System Disease in 1 studies

N(1),N(11)-diethylnorspermine: structure given in first source

Research Excerpts

ExcerptRelevanceReference
"Fifteen patients with advanced solid tumors were entered into a phase I study of DENSPM given by a 1 h i."2.68Unusual central nervous system toxicity in a phase I study of N1N11 diethylnorspermine in patients with advanced malignancy. ( Berghorn, E; Creaven, PJ; Levine, E; Loewen, G; Meropol, NJ; Pendyala, L; Perez, R; Raghavan, D, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Creaven, PJ1
Perez, R1
Pendyala, L1
Meropol, NJ1
Loewen, G1
Levine, E1
Berghorn, E1
Raghavan, D1

Trials

1 trial available for n(1),n(11)-diethylnorspermine and Central Nervous System Disease

ArticleYear
Unusual central nervous system toxicity in a phase I study of N1N11 diethylnorspermine in patients with advanced malignancy.
    Investigational new drugs, 1997, Volume: 15, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Area Under Curve; Biological Availability; Centr

1997